Paris, France

Aurelie Kamoun

USPTO Granted Patents = 2 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Aurelie Kamoun: Innovator in Cancer Diagnosis

Introduction

Aurelie Kamoun is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer diagnosis through her innovative research and development of biomarker proteins.

Latest Patents

Aurelie Kamoun holds a patent for her invention related to bladder cancer biomarker proteins. This invention encompasses a collection of signature peptides representing at least 10 proteins that are utilized for cancer diagnosis and prognosis. It includes an artificial protein comprising these signature peptides and a nucleic acid construct encoding for such an artificial protein. Furthermore, her invention outlines a method for cancer diagnosis and prognosis that involves analyzing at least 10 proteins in a urine sample from a subject. Additionally, it features an immunoassay product that comprises antibodies for detecting these proteins.

Career Highlights

Throughout her career, Aurelie Kamoun has worked with notable organizations, including Polyquant GmbH and Commissariat à l'Énergie Atomique et aux Énergies Alternatives. Her work has been instrumental in advancing the understanding and diagnosis of bladder cancer.

Collaborations

Aurelie has collaborated with esteemed colleagues such as Jerome Garin and Christophe Masselon, contributing to the collective knowledge and innovation in her field.

Conclusion

Aurelie Kamoun's work in developing biomarker proteins for cancer diagnosis exemplifies her commitment to advancing medical science. Her innovative contributions continue to impact the field of oncology significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…